UF Innovate | Sid Martin Biotech Archives - Page 12 of 20

Gainesville Chamber Honors Local Organizations at 2020 Business Awards

The Greater Gainesville Chamber of Commerce hosted their 2020 Business Awards before a limited crowd of guests at the Curtis M. Phillips Center for the Performing Arts and numerous others via live stream.

Communicating With Nematodes for Better Farming

Pheronym was one of the nine finalist teams for the 2020 Ray of Hope Prize®, presented by the Biomimicry Institute and the Ray C. Anderson Foundation. Pheronym increases the effectiveness of commercially available beneficial nematodes (microscopic roundworms) by tapping into their natural communication platform, pheromones.

AGTC Goes Mobile to Avoid Clinical Trial Chaos

When leaders of UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC realized how disruptive COVID-19 might become, they developed a plan—several of them, in fact—to minimize clinical chaos.

Pets, Perseverance, and Manufacturing Facility Bring Biotech Success

Patricia Lawman, co-founder and CEO of the biotech firm Morphogenesis, a UF startup and UF Innovate | Sid Martin Biotech graduate company, has always been amazed at how our bodies can defeat illnesses and usually do it better than drugs.

TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative Free Multi-Dose Delivery of Latanoprost for the Treatment of Glaucoma

UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for the preservative free multi-dose delivery of a proprietary Latanoprost formulation, including the clinical study design for the registration study.

Huvepharma Introduces New Necrotic Enteritis Vaccine Developed by Curtiss Healthcare, Inc.

Huvepharma, Inc., a pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products, has introduced AVERT NE, an innovative new vaccine to help control necrotic enteritis (NE) due to Clostridium perfringens Type A.

Ology Bioservices Awarded $37 Million for Advanced Development of Anti-COVID-19 Monoclonal Antibody Cocktail

UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD) has awarded the company with an agreement valued at $37 million.

UF Innovate | Sid Martin Biotech